Cancer Research News: February 12 – February 26

The FDA approved a new drug, Kadcyla, that kills cancer cells more effectively while potentially reducing side effects.
Men with high-risk prostate cancer undergoing hormone therapy live just as long whether they receive treatment for 18 months or 36 months.
African-Americans and people living in poverty are more likely to present with an emergency colorectal cancer diagnosis.
Daily use of a multivitamin reduced total cancer incidence in men tracked for more than a decade.

Cancer Research News: December 21 – January 17

Overall cancer death rates are declining in America, according to The Annual Report to the Nation on the Status of Cancer, 1975–2009.
The incidence of some cancers associated with HPV has increased.
Last year was the 20th anniversary of the discovery of the Janus kinase (JAK)–signal transducer and activator of transcription (STAT) pathway, both of which have roles in hematologic cancers.
Massachusetts researchers have developed a high-tech camera you can swallow that may be an alternative to endoscopy for cancer diagnosis.

Iclusig, a new drug for the treatment of chronic myeloid leukemia, has received early approval from the FDA.
Dr. Samuel Metz considers whether America has the world’s best cancer care.
Researchers found that pairing cholesterol-reducing drugs called statins with cyclin-dependent kinase inhibitors might more effectively treat certain types of melanomas.
Adjuvant chemotherapy resulted in higher rates of disease-free and overall survival for women with recurrent breast cancer.